Orforglipron — fllwup^ https://fllwup.co/topic/orforglipron/ Track Orforglipron news in real time — Lilly's daily weight-loss pill approaching approval and mass availability. fllwup^ collects the latest Orforglipron headlines from every major source into one live feed — free, no account, no algorithm. Sat, 22 Aug 2026 19:29:19 GMT While Not the First Oral GLP-1, Daily Orforglipron Pill Could Reduce Reliance on Weight Loss Injectionshttps://news.google.com/rss/articles/CBMi2AFBVV95cUxNZVE5bGpKbktkN3dJUE50ZXdnSmRoeFRqam95U2JiRnFUaEZNTUM3RkhIcVp0WXF5Qm5pYXJ6NXBrZFFHSDZZdjlLVWx2eTZ1Zks4Vjg0TVhUVFlWdjNLOE96bXgtWThlV1paZ3RMdlBjeXJKSW5OVDRfYUpCQkhMZVhtSWFHUWs2VndZN2NvUGlzZjJfal9nTC0yWTZ4bWxQS0hVS1hEeHUwbTBTM1VTYTV6SXJDaWZFOVdOakYzRExsem80REZucDZHU2ptQV9Fa1JZMm15S1c?oc=5Discover Magazine 9 Foundayo (Orforglipron) Side Effects You Should Know Abouthttps://news.google.com/rss/articles/CBMiaEFVX3lxTE5BNjJJR2Z2LVJsNDBWcTl1RzhTN05fZnFIWmVJYmR2WTVZdU5BR2ZtdENJSmo0N01DS0cxOXVoNVMyVnNyd19LdzU1SFBDY1p6aTZMaDdIVjFwMm5iazdVVFFaVHRudWx6?oc=5GoodRx Weight-loss pills: can orforglipron preserve weight loss after Mounjaro?https://news.google.com/rss/articles/CBMivgFBVV95cUxNc0gwb1ozT2V6WC1QczYxcDhFVS1QbktTbVA3N1VwdWhMTlhGOWVHM1dac0YyTVVXaE9UalFvT1JUcGV4bEU3elotRVBfa1ZXWGZ4MUJGd3NoUTdNT2EtUHlVQXB4UDJ5dnB0VHRPRFVBeVpXYUYxLXNuR25ndWxDVy1DMlZQSm9zLVB5RWxmc2ZIaC1qdTRWaGhSQjVRaDUwam5mQWI1RVY2SndIaGUwUDZ1Z2hheEZzU2o0SUl3?oc=5British Heart Foundation Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trialhttps://news.google.com/rss/articles/CBMiX0FVX3lxTE1VeTcySUgzbHhHaDFNdmhMZXlCYzNYNF9ZTmJiU0ZJVDhPMzF1ZS1Fdm5sQWZua2h0djRBMFRHVUxsVHN4QXM2S1A3NTctVTRBVUdHdnNpR3U1TUU3WEs0?oc=5Nature What Is Orforglipron? Inside a CU Anschutz Clinical Trial for a New Oral GLP-1 Weight-Loss Drughttps://news.google.com/rss/articles/CBMi0AFBVV95cUxPanhrWEpSQUw5RVpKOGw1dUI2bnVNRXVxV0swdExvSnlsa1RWNWxISTNjWkFCMHpQQTVVLTU3UnN4dGF2YTR4Vi1tNFAzbjJEbEV3VHBiMEx2NjllektaR3U0X0dBQ3NpRnlEenY3RWs2Vk1CSFBrNkhpVHQ1cjRsRkpBbUpTVXRCd3ZfYWVDWUVnbjZaR1hQVFNnYllEbzFqTFhUREtkcGMzOE5pdkVaelJGUjdnc0RQVnJ5QTRsV0hBa1R3S1pwMXEwM05FNlJr0gHgAUFVX3lxTE5Qa25lemZKRElHVExOcDZRMkg4QV9DTDFYSjN5c1N6Vm5SSFBUaUgzVl85cWt0R0dEUWdOaTU0d2FaR0Z2VklJQUJBLTI5UHBfb2c1Tjc1ZkVKM0tTaU5XZ0R0OGVpX0k1Z0lKWXRpYU5lZHJZTURLSldLN2xvWXF3WVBOYVd6aW1oSUJoRF83dzNzaFJyNDRtSUg2RFhodVEyRFliZHZRNHlTdW5DSEd3QkpacDk4aFI0NENjQ3lXX0dLVFotUGJMQ3NpOTlIbjJkV2pCbWh6ZTVfMzMzdVFB?oc=5University of Colorado Anschutz Orforglipron offers greater weight loss for people with diabetes than oral semaglutidehttps://news.google.com/rss/articles/CBMizwFBVV95cUxQdXN4VlBxYVppWktfTEN1d0VvYUtfbWxHQTk1RFNqZURacVFDYlBLeXBQQzhoWThjTzhxc1B5Zm5QRDd5R0JkRFdQVEVucjJWQVQtRjFfekNtbTJzTDdtTGg3ZjRTcFY5U2t3SENkU2FQX3dJSkY5RUFXV012bXEyZ0FaWnVjSk00Y3ZMNUZnNGRNRHVxQkQwN1Y3SklfZzFrNmc4b1pZa095aFRCXzJkQ3JkcEJQMExKcVU1MFlFTVRYWTFZM25uYnluTzd2TW8?oc=5The Pharmaceutical Journal Lilly's oral GLP-1 Foundayo (orforglipron) delivered superior A1C control and weight loss in three pivotal type 2 diabetes trialshttps://news.google.com/rss/articles/CBMiwgFBVV95cUxQS1NMUkRWOUszTUhNSjRfWG1IUkhBaHFDVUVxTm8zem80dy0zNnZxMS1xOHMyMUc3MG5DX01xNS04RmJmMmZ4NF9VU1ZNVUtZLWc1S04wUGpESG9oT2x1cEpaeGtldUpUNDV4OWZyMlJKLXNLN01GM1ZWWjFFQXpiY01yM3U1QnZlUnhGcVlBQ2xqaU9ZU200clVXMWlHcFJ2VHJ5cTlQS1p2QjVHNUUzd1VWeFdUVlJ3U21ZSlg5YmhVZw?oc=5Eli Lilly and Company Pharmacokinetic Bioequivalence of Orforglipron Tablets and Capsules in Healthy Participants With Obesity or Overweighthttps://news.google.com/rss/articles/CBMiU0FVX3lxTE01OG1CYXdsdXZUT0QycWx6YzF3ZjltWFo5N1hvU29DTG9BTVB2bl84LUVDSFEwdGJ6ekJ5ckpLdGlITmllT1dMN1ZmOVRCdEpETVhn?oc=5National Institutes of Health (NIH) | (.gov) UK first in Europe to authorise orforglipron for weight management and type 2 diabeteshttps://news.google.com/rss/articles/CBMivgFBVV95cUxNUEhmYl8yb05MR0xTM3drRHNfY1FweXJBa1RYN3pvYmZib0JwSXVyWXZTSlNwNXZmSGw5MllUY1pNTXRfYkxnOWZPV1FQY2FTeXlMV1paRW5iLUVCOThPNGlkUkVKSVV3UFpEMHZUMUpHa0tfdDZya0lkSTFMdGxESkFlbHpMZ1NWVWhLMEhUaVV4QkFMUkp1RlNZQVUxMXhzdHNqd2N2NV9pMWlvQnlYeGdmY28tV0hnb0ZGeE9R?oc=5GOV.UK What to Know About Foundayo, the New Pill GLP-1 for Weight Losshttps://news.google.com/rss/articles/CBMiuwFBVV95cUxNY21JLTllUnNYcjBWeVY3X1pwak52ZmFZOXlWWVRxTWNRMmZaMjhZZUdjZGdKQnlsRER3aThRU2JuMlVWUFg2bF90UWsyUXAxWTFfdkpFZWdCMjJHNUZreW1objNWNkQxYnhwSk9LMVpwNWhvODdnVzNWMUJ0bm9jLTBVYVZJMlNJZnpxMHFLaGRoaUUybjhLckdiMmRta2Znd3g4Rk9wMkZ1T2o0eXJYMXRBUHFBSmkwV0Zj?oc=5Health US News